全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Yang Liu , Wen Cao , Yu Liu ...
来源:[J].BMC Anesthesiology(IF 1.188), 2017, Vol.17 (1)Springer
摘要:... Since the liver is the major organ for rocuronium metabolism, the question of whether NMB of rocuronium would change with the variation of liver perfusion during pneumoperitoneum during laparoscopic surgery merits investigation.
作者:Sangseok Lee , Young Jin Ro , Won Uk Koh ...
来源:[J].BMC Anesthesiology(IF 1.188), 2015, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)We conducted a prospective, randomized, multicenter study to evaluate the differences in the blocking effect of different doses of rocuronium between sevoflurane- or propofol-remifentanil anesthesia in an Asian population.(#br) Methods(#br)A tota...
作者:Mayuko Kanazawa , Aiji Sato (Boku) , Yoko Okumura ...
来源:[J].BMC Anesthesiology(IF 1.188), 2019, Vol.19 (1), pp.1-6DOAJ
摘要:Abstract Background Rocuronium bromide (RB) is known to cause vascular pain. Although there have been a few reports that diluted administration causes less vascular pain, there have been no studies investigating diluted administration and the onset time of muscle relaxation. Ther...
作者:Marie T. Aouad , Waseem S. Alfahel , Roland N. Kaddoum ...
来源:[J].BMC Anesthesiology(IF 1.188), 2017, Vol.17 (1)Springer
摘要:Sugammadex reverses the effect of rocuronium more rapidly and effectively than neostigmine, at all levels of neuromuscular blockade (NMB). However, its cost is prohibitive. The combination of half dose sugammadex with neostigmine would be non-inferior to full dose sugammadex for ...
作者:Eva Anzenbacherova , Alena Spicakova , Lenka Jourova ...
来源:[J].Journal of Pharmacological Sciences(IF 2.15), 2015, Vol.127 (2), pp.190-195Elsevier
摘要:Abstract(#br)Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam, possible ...
作者:Eva Anzenbacherova , Alena Spicakova , Lenka Jourova ...
来源:[J].Journal of Pharmacological Sciences(IF 2.15), 2015, Vol.127 (2), pp.190-195DOAJ
摘要:Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam, possible interactio...
作者:Moira H. D. Bruintjes , Andries E. Braat , Albert Dahan ...
来源:[J].Trials(IF 2.206), 2017, Vol.18 (1)Springer
摘要:Postoperative recovery after live donor nephrectomy is largely determined by the consequences of postoperative pain and analgesia consumptions. The use of deep neuromuscular blockade has been shown to reduce postoperative pain scores after laparoscopic surgery. In this study, we ...
作者:T. Ledowski , A. Goodwin-Walters , P. Quinn ...
来源:[J].BMC Anesthesiology(IF 1.188), 2017, Vol.17 (1)Springer
摘要:The use of neuromuscular blocking agents has previously been suggested to facilitate the dissection of the latissimus dorsi muscle during breast reconstructive surgery. The aim of this study was to quantify the influence of deep muscle relaxation on the force required to lift the...
作者:Dilek MEMİŞ , Müşerref OTKUN , Meral BAHAR ...
来源:[J].Trakya Universitesi Tip Fakultesi Dergisi(IF 0.113), 2009, Vol.26 (2), pp.100DOAJ
摘要:Objectives: We studied in vivo growth of Escherichia coli in atracurium, rocuronium, mivacurium, cisatracurium, pancuronium, and vecuronium.Patients and Methods: The pathogen was exposed to atracurium, rocuronium, mivacurium, cisatracurium, pancuronium and vecuronium for 2, 4, 6,...
作者:M Çakirgöz , I Demirel , E Duran ...
来源:[J].Nigerian Journal of Clinical Practice(IF 0.263), 2018, Vol.21 (1), pp.43-48Wolters Kluwer
摘要:Aim: This prospectively-planned, randomized, double-blind and placebo-controlled study aims to evaluate the effect of 1200 mg gabapentin premedication on the incidence and severity of propofol and rocuronium injection pain. Method: One hundred patients, between 18-60 years of ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×